Become an Incathlab member and receive full access to its content!
Registration Login
Case summary
Patient: male 77 y
Dyspnea and angina since several months
NSTEMI 26.11.16
3 vessels disease: several stenosis LAD, CX and RCA
culprit lesion LAD (with thrombus)
CTO IM branch und PD of RCA
Syntax score: 28
LVEF: 45%
Inferior and apikal akinesia
No valvular heart disease
Renal function: eGFR = 85 ml/min/1.73m2
CVRF: aHT, dysplidemia
How to treat this patient?
Syntax score: 28
EuroSCORE II: 2.2
STS-score: 1.2 for mortality
9.4 for morbiditiy and mortality
Proposed treatment: CABG, but patient refused
Todays planned procedures:
PCI of the LAD and diagonal branch
Ev. RCX PCI
Protocol
OptiRAY® (Ioversol)
Concentration 300 mgI/mL
Flow rate: 3.5 mL/ s
Volume: 112 mL
Total exposure : 0.8 Gy
Exposure time: 27 minutes
15 images / s low dose Philips
57 images mostly fluoro
Last update : 2021-06-09
OptiRAY® / Guerbet
Join the Discussion
Suggestions
Retry of an ostial LAD CTO, previous antegrade failure with Gaia family
Alex & The Young Generation - Ep.11
San Francisco : Wednesday, October 16th 2024 from 10am to 10:45am (GMT+2)
New York : Wednesday, October 16th 2024 from 01pm to 01:45pm (GMT+2)
Buenos Aires : Wednesday, October 16th 2024 from 02pm to 02:45pm (GMT+2)
Reykjavik : Wednesday, October 16th 2024 from 05pm to 05:45pm (GMT+2)
London / Dublin : Wednesday, October 16th 2024 from 06pm to 06:45pm (GMT+2)
Paris / Berlin : Wednesday, October 16th 2024 from 07pm to 07:45pm (GMT+2)
Istanbul : Wednesday, October 16th 2024 from 08pm to 08:45pm (GMT+2)
Moscou / Dubaï : Wednesday, October 16th 2024 from 09pm to 09:45pm (GMT+2)
Bangkok : Thursday, October 17th 2024 from 12am to 12:45am (GMT+2)
Shanghai : Thursday, October 17th 2024 from 01am to 01:45am (GMT+2)
Tokyo : Thursday, October 17th 2024 from 02am to 02:45am (GMT+2)
Sydney : Thursday, October 17th 2024 from 04am to 04:45am (GMT+2)
Wellington : Thursday, October 17th 2024 from 06am to 06:45am (GMT+2)
Guides de 1ère intention :
les trucs et les astuces qui aident en pratique
San Francisco : Wednesday, May 17th 2017 from 02:30am to 03:30am (GMT+2)
New York : Wednesday, May 17th 2017 from 05:30am to 06:30am (GMT+2)
Buenos Aires : Wednesday, May 17th 2017 from 06:30am to 07:30am (GMT+2)
Reykjavik : Wednesday, May 17th 2017 from 09:30am to 10:30am (GMT+2)
London / Dublin : Wednesday, May 17th 2017 from 10:30am to 11:30am (GMT+2)
Paris / Berlin : Wednesday, May 17th 2017 from 11:30am to 12:30pm (GMT+2)
Istanbul : Wednesday, May 17th 2017 from 12:30pm to 01:30pm (GMT+2)
Moscou / Dubaï : Wednesday, May 17th 2017 from 01:30pm to 02:30pm (GMT+2)
Bangkok : Wednesday, May 17th 2017 from 04:30pm to 05:30pm (GMT+2)
Shanghai : Wednesday, May 17th 2017 from 05:30pm to 06:30pm (GMT+2)
Tokyo : Wednesday, May 17th 2017 from 06:30pm to 07:30pm (GMT+2)
Sydney : Wednesday, May 17th 2017 from 08:30pm to 09:30pm (GMT+2)
Wellington : Wednesday, May 17th 2017 from 10:30pm to 11:30pm (GMT+2)
Alexander P. Why DES in distal LAD ? BVS Absorb?
Daniel W. Hi Alexander. Thank you for your question. We know from the Absorb data that scaffolds perform worse than DES in smaller vessels, associated with a higher MACE rate. An alternative could be treating small vessels with DCB. The BASKET small study result will be presented in 2018 (DES vs DCB in small vessels). DCB are good in our experience when you have TIMI flow III, no more than a dissection A or B, and less than 30% residual stenosis.